The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

According to the American Academy of Ophthalmology, glaucoma is a group of eye conditions that damage the optic nerve, often ...

Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

This is a higher dose, longer-acting form of the drug, and it’s used to treat wet AMD, diabetic retinopathy ... treatment with Eylea can cause a long-term increase in the pressure in your eye.

Experiencing fatigue, blurred vision, and unexplained weight loss, a young man sought medical consultation and was informed ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

Ozempic has made headlines as a go-to medication for managing diabetes and aiding weight loss, but its popularity comes with ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

This condition is called diabetic retinopathy. In its early stages ... are at higher risk of developing these conditions, ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.